Organization
Nanjing Leads Biolabs
10 clinical trials
Clinical trial
A Multicenter Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LBL-007 in Combination With Tislelizumab in the Treatment of MalignanciesStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
An Open-label, Multicenter Phase Ib/II Clinical Study to Evaluate the Safety and Efficacy of LBL-024 Combined With Etoposide and Platinum in the First-line Treatment of Patients With Advanced Neuroendocrine Carcinoma (NEC)Status: Recruiting, Estimated PCD: 2026-11-20
Clinical trial
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of LBL-024 in Patients With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
A Multicenter, Open Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of LBL-019 Monotherapy or Combination Anti-PD-1 Antibody in Patients With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2025-03-22
Clinical trial
A Multicenter Phase Ib/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LBL-007 in Combination With Toripalimab in the Treatment of Advanced MalignanciesStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
An Open-label, Multi-center, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti Tumor Activity of LBL-015 in Patients With Advanced Malignant TumorsStatus: Recruiting, Estimated PCD: 2024-10-01
Clinical trial
A Multicenter, Open Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of LBL-033 in the Treatment of Patients With Advanced Malignant Tumors.Status: Recruiting, Estimated PCD: 2026-03-31
Clinical trial
A Multicenter, Open-label, Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of LBL-034 in Patients With Relapsed/Refractory Multiple MyelomaStatus: Recruiting, Estimated PCD: 2026-10-20
Clinical trial
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of LBL-003 Injection in Patients With Advanced MalignanciesStatus: Recruiting, Estimated PCD: 2024-03-22
Clinical trial
A Phase I Multi-center Study to Evaluate the Safety ,Tolerability and Efficacy of LBL-007 Combined With Toripalimab or LBL-007 Combined With Toripalimab and Axitinib Tablets in the Treatment of Unresectable or Metastatic MelanomaStatus: Recruiting, Estimated PCD: 2024-08-10